The store will not work correctly when cookies are disabled.
8-Methoxy-4-phenylamino-quinoline-3-carboxylic acid ethyl ester hydrochloride (0.7H2o)
ID: ALA542457
PubChem CID: 20529025
Max Phase: Preclinical
Molecular Formula: C19H19ClN2O3
Molecular Weight: 322.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cnc2c(OC)cccc2c1Nc1ccccc1.Cl
Standard InChI: InChI=1S/C19H18N2O3.ClH/c1-3-24-19(22)15-12-20-18-14(10-7-11-16(18)23-2)17(15)21-13-8-5-4-6-9-13;/h4-12H,3H2,1-2H3,(H,20,21);1H
Standard InChI Key: DGFFVGQOZXGJAE-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
5.1003 1.1305 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9122 1.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 2.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9138 2.4966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 3.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2109 0.7445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2995 -2.9981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5121 1.4924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5835 5.2544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8880 3.0076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3396 -3.5967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5506 0.8910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1852 3.7608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8807 6.0076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1815 5.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 2 0
4 6 1 0
5 6 2 0
3 7 1 0
3 8 2 0
5 8 1 0
2 9 1 0
6 10 1 0
7 11 2 0
9 12 1 0
7 13 1 0
4 14 1 0
10 15 1 0
14 16 2 0
10 17 2 0
16 17 1 0
13 18 1 0
12 19 2 0
12 20 1 0
15 21 1 0
18 22 1 0
20 23 2 0
19 24 1 0
23 25 1 0
24 25 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.36 | Molecular Weight (Monoisotopic): 322.1317 | AlogP: 4.16 | #Rotatable Bonds: 5 |
Polar Surface Area: 60.45 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.06 | CX LogP: 5.07 | CX LogD: 5.07 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.71 | Np Likeness Score: -1.08 |
References
1. Ife RJ, Brown TH, Keeling DJ, Leach CA, Meeson ML, Parsons ME, Reavill DR, Theobald CJ, Wiggall KJ.. (1992) Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines., 35 (18): [PMID:1326634] [10.1021/jm00096a018] |